相关实验视频
Updated: Sep 10, 2025
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
446
双极性抑郁症中的抗抑郁药缓解和躁狂转换:倾向性评分分析
Paul A Vöhringer1,2,3,4, Sergio A Barroilhet1,2,3,5, Bárbara A Palma1,2
1Departamento de Psiquiatría y Salud Mental, Hospital Clínico Universidad de Chile, Santiago, Chile.
Acta psychiatrica Scandinavica
|August 22, 2025
概括
在一项大型研究中,在双相抑郁症中使用抗抑郁药物并没有增加躁狂风险或改善缓解率. 有效治疗双极性抑郁症需要进一步的研究.
科学领域:
- 精神病学
- 药理学
- 临床心理学
背景情况:
- 抗抑郁药经常用于双相情绪障碍,尽管有效性和诱发躁狂的可能性有限.
- 对抗抑郁药物在治疗双极性抑郁症的安全性和有效性存在担忧.
研究的目的:
- 使用大量自然主义队列评估双极性抑郁症的抗抑郁药治疗结果.
- 评估抗抑郁药对症状缓解和躁狂的影响.
- 通过倾向评分分析来最大限度地减少指示偏差.
主要方法:
- 在STEP- BD队列 (n=2166) 上进行了倾向性评分 (PS) 分析.
- 倾向性得分用于匹配暴露于抗抑郁药物和未暴露的个体.
- 考克斯回归模型估计了躁狂转变和缓解的危险比率,经过PS调整.
主要成果:
- 抗抑郁药物暴露与躁狂转变的可能性增加没有显著关联 (PS调整HR:0. 77;95%CI:0. 51- 1. 08).
- 症状缓解与使用抗抑郁药物也没有显著关联 (PS调整后HR:1. 02;95% CI:0. 87-1.23).
- 这项研究包括1085名暴露于抗抑郁药物和1081名未暴露的患者,平均随访时间为182.5天.
结论:
- 在双相抑郁症中使用抗抑郁药时,倾向性评分的调整没有增加躁狂转变的风险或改善缓解.
- 这些发现凸显了对双极性抑郁症的替代治疗策略的需要.
- 这项研究强调了严格的统计方法在自然主义队列研究中的重要性.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
01:30Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:28Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
01:25Antidepressant Drugs: Overview
750
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
750